Financhill
Sell
50

ALGN Quote, Financials, Valuation and Earnings

Last price:
$192.24
Seasonality move :
1.03%
Day range:
$189.27 - $193.45
52-week range:
$141.74 - $263.24
Dividend yield:
0%
P/E ratio:
35.02x
P/S ratio:
3.60x
P/B ratio:
3.67x
Volume:
672.6K
Avg. volume:
848.8K
1-year change:
-23.27%
Market cap:
$13.9B
Revenue:
$4B
EPS (TTM):
$5.49

Price Performance History

Performance vs. Valuation Benchmarks

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Competitors

Company Revenue Forecast Earnings Forecast Revenue Growth Forecast Earnings Growth Forecast Analyst Price Target Median
ALGN
Align Technology
$1.1B $2.57 2.9% 100.44% $233.81
BIOLQ
Biolase
$13.5M -$0.01 3.78% -99.71% $1.2000
MLSS
Milestone Scientific
$2.6M -$0.01 40.26% -50% $2.13
NVST
Envista Holdings
$640.2M $0.23 3.84% 406.36% $19.63
SOLV
Solventum
$2.1B $1.45 1.89% 185.16% $85.04
XRAY
Dentsply Sirona
$931.5M $0.50 -5.4% 234.18% $18.18
Company Price Analyst Target Market Cap P/E Ratio Dividend per Share Dividend Yield Price / LTM Sales
ALGN
Align Technology
$192.27 $233.81 $13.9B 35.02x $0.00 0% 3.60x
BIOLQ
Biolase
$0.0091 $1.2000 $333K -- $0.00 0% 0.00x
MLSS
Milestone Scientific
$0.62 $2.13 $48.7M -- $0.00 0% 5.77x
NVST
Envista Holdings
$19.75 $19.63 $3.3B -- $0.00 0% 1.36x
SOLV
Solventum
$73.03 $85.04 $12.6B 33.81x $0.00 0% 1.53x
XRAY
Dentsply Sirona
$15.81 $18.18 $3.2B -- $0.16 4.05% 0.86x
Company Total Debt / Total Capital Beta Debt to Equity Quick Ratio
ALGN
Align Technology
-- 2.280 -- 0.99x
BIOLQ
Biolase
142.17% -3.027 714.45% 0.23x
MLSS
Milestone Scientific
-- 1.027 -- 0.62x
NVST
Envista Holdings
31.74% 2.114 47.7% 1.68x
SOLV
Solventum
70.81% 1.088 60.15% 0.64x
XRAY
Dentsply Sirona
53.74% 1.179 78.42% 0.56x
Company Gross Profit Operating Income Return on Invested Capital Return on Common Equity EBIT Margin Free Cash Flow
ALGN
Align Technology
$680.1M $135.3M 10.72% 10.72% 13.81% $27.4M
BIOLQ
Biolase
$4.4M -$695K -129.74% -21668.17% -7.48% -$4.5M
MLSS
Milestone Scientific
$1.6M -$2M -79.98% -79.98% -89.49% -$1M
NVST
Envista Holdings
$336M $47.4M -24.02% -34.78% 6.21% -$5.6M
SOLV
Solventum
$1.1B $152M 3.34% 11.75% 6.86% -$80M
XRAY
Dentsply Sirona
$466M $70M -19.2% -35.57% 7.17% -$12M

Align Technology vs. Competitors

  • Which has Higher Returns ALGN or BIOLQ?

    Biolase has a net margin of 9.52% compared to Align Technology's net margin of -13.16%. Align Technology's return on equity of 10.72% beat Biolase's return on equity of -21668.17%.

    Company Gross Margin Earnings Per Share Invested Capital
    ALGN
    Align Technology
    69.45% $1.27 $3.8B
    BIOLQ
    Biolase
    40.39% -$0.04 $12.4M
  • What do Analysts Say About ALGN or BIOLQ?

    Align Technology has a consensus price target of $233.81, signalling upside risk potential of 21.6%. On the other hand Biolase has an analysts' consensus of $1.2000 which suggests that it could grow by 21878.02%. Given that Biolase has higher upside potential than Align Technology, analysts believe Biolase is more attractive than Align Technology.

    Company Buy Ratings Hold Ratings Sell Ratings
    ALGN
    Align Technology
    9 5 0
    BIOLQ
    Biolase
    1 1 0
  • Is ALGN or BIOLQ More Risky?

    Align Technology has a beta of 1.633, which suggesting that the stock is 63.291% more volatile than S&P 500. In comparison Biolase has a beta of 0.028, suggesting its less volatile than the S&P 500 by 97.213%.

  • Which is a Better Dividend Stock ALGN or BIOLQ?

    Align Technology has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Biolase offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Align Technology pays -- of its earnings as a dividend. Biolase pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios ALGN or BIOLQ?

    Align Technology quarterly revenues are $979.3M, which are larger than Biolase quarterly revenues of $10.9M. Align Technology's net income of $93.2M is higher than Biolase's net income of -$1.4M. Notably, Align Technology's price-to-earnings ratio is 35.02x while Biolase's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Align Technology is 3.60x versus 0.00x for Biolase. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    ALGN
    Align Technology
    3.60x 35.02x $979.3M $93.2M
    BIOLQ
    Biolase
    0.00x -- $10.9M -$1.4M
  • Which has Higher Returns ALGN or MLSS?

    Milestone Scientific has a net margin of 9.52% compared to Align Technology's net margin of -89.35%. Align Technology's return on equity of 10.72% beat Milestone Scientific's return on equity of -79.98%.

    Company Gross Margin Earnings Per Share Invested Capital
    ALGN
    Align Technology
    69.45% $1.27 $3.8B
    MLSS
    Milestone Scientific
    73.8% -$0.02 $4.5M
  • What do Analysts Say About ALGN or MLSS?

    Align Technology has a consensus price target of $233.81, signalling upside risk potential of 21.6%. On the other hand Milestone Scientific has an analysts' consensus of $2.13 which suggests that it could grow by 242.69%. Given that Milestone Scientific has higher upside potential than Align Technology, analysts believe Milestone Scientific is more attractive than Align Technology.

    Company Buy Ratings Hold Ratings Sell Ratings
    ALGN
    Align Technology
    9 5 0
    MLSS
    Milestone Scientific
    1 0 0
  • Is ALGN or MLSS More Risky?

    Align Technology has a beta of 1.633, which suggesting that the stock is 63.291% more volatile than S&P 500. In comparison Milestone Scientific has a beta of 0.801, suggesting its less volatile than the S&P 500 by 19.924%.

  • Which is a Better Dividend Stock ALGN or MLSS?

    Align Technology has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Milestone Scientific offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Align Technology pays -- of its earnings as a dividend. Milestone Scientific pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios ALGN or MLSS?

    Align Technology quarterly revenues are $979.3M, which are larger than Milestone Scientific quarterly revenues of $2.2M. Align Technology's net income of $93.2M is higher than Milestone Scientific's net income of -$2M. Notably, Align Technology's price-to-earnings ratio is 35.02x while Milestone Scientific's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Align Technology is 3.60x versus 5.77x for Milestone Scientific. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    ALGN
    Align Technology
    3.60x 35.02x $979.3M $93.2M
    MLSS
    Milestone Scientific
    5.77x -- $2.2M -$2M
  • Which has Higher Returns ALGN or NVST?

    Envista Holdings has a net margin of 9.52% compared to Align Technology's net margin of 2.92%. Align Technology's return on equity of 10.72% beat Envista Holdings's return on equity of -34.78%.

    Company Gross Margin Earnings Per Share Invested Capital
    ALGN
    Align Technology
    69.45% $1.27 $3.8B
    NVST
    Envista Holdings
    54.47% $0.10 $4.4B
  • What do Analysts Say About ALGN or NVST?

    Align Technology has a consensus price target of $233.81, signalling upside risk potential of 21.6%. On the other hand Envista Holdings has an analysts' consensus of $19.63 which suggests that it could fall by -0.63%. Given that Align Technology has higher upside potential than Envista Holdings, analysts believe Align Technology is more attractive than Envista Holdings.

    Company Buy Ratings Hold Ratings Sell Ratings
    ALGN
    Align Technology
    9 5 0
    NVST
    Envista Holdings
    4 9 1
  • Is ALGN or NVST More Risky?

    Align Technology has a beta of 1.633, which suggesting that the stock is 63.291% more volatile than S&P 500. In comparison Envista Holdings has a beta of 1.004, suggesting its more volatile than the S&P 500 by 0.421%.

  • Which is a Better Dividend Stock ALGN or NVST?

    Align Technology has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Envista Holdings offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Align Technology pays -- of its earnings as a dividend. Envista Holdings pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios ALGN or NVST?

    Align Technology quarterly revenues are $979.3M, which are larger than Envista Holdings quarterly revenues of $616.9M. Align Technology's net income of $93.2M is higher than Envista Holdings's net income of $18M. Notably, Align Technology's price-to-earnings ratio is 35.02x while Envista Holdings's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Align Technology is 3.60x versus 1.36x for Envista Holdings. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    ALGN
    Align Technology
    3.60x 35.02x $979.3M $93.2M
    NVST
    Envista Holdings
    1.36x -- $616.9M $18M
  • Which has Higher Returns ALGN or SOLV?

    Solventum has a net margin of 9.52% compared to Align Technology's net margin of 6.62%. Align Technology's return on equity of 10.72% beat Solventum's return on equity of 11.75%.

    Company Gross Margin Earnings Per Share Invested Capital
    ALGN
    Align Technology
    69.45% $1.27 $3.8B
    SOLV
    Solventum
    53.82% $0.78 $11.2B
  • What do Analysts Say About ALGN or SOLV?

    Align Technology has a consensus price target of $233.81, signalling upside risk potential of 21.6%. On the other hand Solventum has an analysts' consensus of $85.04 which suggests that it could grow by 16.45%. Given that Align Technology has higher upside potential than Solventum, analysts believe Align Technology is more attractive than Solventum.

    Company Buy Ratings Hold Ratings Sell Ratings
    ALGN
    Align Technology
    9 5 0
    SOLV
    Solventum
    2 6 0
  • Is ALGN or SOLV More Risky?

    Align Technology has a beta of 1.633, which suggesting that the stock is 63.291% more volatile than S&P 500. In comparison Solventum has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.

  • Which is a Better Dividend Stock ALGN or SOLV?

    Align Technology has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Solventum offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Align Technology pays -- of its earnings as a dividend. Solventum pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios ALGN or SOLV?

    Align Technology quarterly revenues are $979.3M, which are smaller than Solventum quarterly revenues of $2.1B. Align Technology's net income of $93.2M is lower than Solventum's net income of $137M. Notably, Align Technology's price-to-earnings ratio is 35.02x while Solventum's PE ratio is 33.81x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Align Technology is 3.60x versus 1.53x for Solventum. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    ALGN
    Align Technology
    3.60x 35.02x $979.3M $93.2M
    SOLV
    Solventum
    1.53x 33.81x $2.1B $137M
  • Which has Higher Returns ALGN or XRAY?

    Dentsply Sirona has a net margin of 9.52% compared to Align Technology's net margin of 2.28%. Align Technology's return on equity of 10.72% beat Dentsply Sirona's return on equity of -35.57%.

    Company Gross Margin Earnings Per Share Invested Capital
    ALGN
    Align Technology
    69.45% $1.27 $3.8B
    XRAY
    Dentsply Sirona
    53.02% $0.10 $4.3B
  • What do Analysts Say About ALGN or XRAY?

    Align Technology has a consensus price target of $233.81, signalling upside risk potential of 21.6%. On the other hand Dentsply Sirona has an analysts' consensus of $18.18 which suggests that it could grow by 14.98%. Given that Align Technology has higher upside potential than Dentsply Sirona, analysts believe Align Technology is more attractive than Dentsply Sirona.

    Company Buy Ratings Hold Ratings Sell Ratings
    ALGN
    Align Technology
    9 5 0
    XRAY
    Dentsply Sirona
    2 13 0
  • Is ALGN or XRAY More Risky?

    Align Technology has a beta of 1.633, which suggesting that the stock is 63.291% more volatile than S&P 500. In comparison Dentsply Sirona has a beta of 0.944, suggesting its less volatile than the S&P 500 by 5.559%.

  • Which is a Better Dividend Stock ALGN or XRAY?

    Align Technology has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Dentsply Sirona offers a yield of 4.05% to investors and pays a quarterly dividend of $0.16 per share. Align Technology pays -- of its earnings as a dividend. Dentsply Sirona pays out -13.85% of its earnings as a dividend.

  • Which has Better Financial Ratios ALGN or XRAY?

    Align Technology quarterly revenues are $979.3M, which are larger than Dentsply Sirona quarterly revenues of $879M. Align Technology's net income of $93.2M is higher than Dentsply Sirona's net income of $20M. Notably, Align Technology's price-to-earnings ratio is 35.02x while Dentsply Sirona's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Align Technology is 3.60x versus 0.86x for Dentsply Sirona. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    ALGN
    Align Technology
    3.60x 35.02x $979.3M $93.2M
    XRAY
    Dentsply Sirona
    0.86x -- $879M $20M

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Will GoodRX Stock Bounce Back?
Will GoodRX Stock Bounce Back?

GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…

Will FCX Benefit From Tariffs?
Will FCX Benefit From Tariffs?

Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…

Can Levi Stock Double?
Can Levi Stock Double?

Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…

Stock Ideas

Buy
71
Is NVDA Stock a Buy?

Market Cap: $4.2T
P/E Ratio: 59x

Buy
51
Is MSFT Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 43x

Sell
40
Is AAPL Stock a Buy?

Market Cap: $3.1T
P/E Ratio: 35x

Alerts

Buy
72
SBET alert for Jul 18

SharpLink Gaming [SBET] is down 2.6% over the past day.

Buy
68
MCRI alert for Jul 18

Monarch Casino & Resort [MCRI] is up 19.81% over the past day.

Sell
41
NEGG alert for Jul 18

Newegg Commerce [NEGG] is up 17.85% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock